OVERVIEW

Managing High-Risk Cutaneous SCC is organized by Med Learning Group and will be held from Mar 19, 2019 - Mar 19, 2020.

Target Audience:
This activity is designed to meet the educational needs of oncology nurses and other healthcare providers involved in the care of patients with recurrent or cutaneous squamous cell carcinoma.

Accreditation: 
Credit Designation Statement
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent for their participation in the online activity.

Nursing Credit Information
Purpose:
This program would be beneficial for nurses involved in the long-term treatment and management of patients with cutaneous squamous cell carcinoma cutaneous squamous cell carcinoma. CNE Credits: 1.0 ANCC Contact Hour(s).

Description:
This case-based activity will cover the treatment and management of patients with cancer who are treated with or are eligible for treatment with recurrent or cutaneous squamous cell carcinoma.

Learning Objectives:
Upon completion of the program, attendees should be able to:
• Review the immune escape mechanisms that contribute to the pathogenesis of cutaneous squamous cell carcinoma
• Evaluate the new AJCC 8 cancer staging manual for head and neck cSCC and its application to clinical practice
• Discuss the predictive features and risk factors for local recurrence or metastatic cSCC carcinoma and stratify patient risk for systemic disease
• Describe the emerging immunotherapy clinical trial data in the treatment of advanced or metastatic cSCC

Additional details will be posted as soon as they are available.

Credits
  • 1 AMA PRA Category 1
  • 1 CNE
  • SPECIALITIES

    DermatologyPlastic SurgeryOtorhinolaryngology

    RELATED ONLINE COURSES

    Webcast

    Ophthalmology
    2.5 AAPA
    More actions
    US$299

    Webcast

    Emergency Medicine
    More actions
    US$200

    Webcast

    Emergency Medicine
    17 AMA PRA Category 1 Credits™
    ...
    More actions
    US$299